Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 29: 2068-2072, 1983;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Boever, J.
Right arrow Articles by Vandekerckhove, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Boever, J.
Right arrow Articles by Vandekerckhove, D.

Clinical Chemistry, Vol 29, 2068-2072, Copyright © 1983 by American Association for Clinical Chemistry

Solid-phase chemiluminescence immunoassay for plasma estradiol-17 beta during gonadotropin therapy compared with two radioimmunoassays

J De Boever, F Kohen and D Vandekerckhove

Estradiol in plasma was determined with a simple solid-phase immunoassay based on chemiluminescence in patients undergoing ovulation induction. In the assay, we use a purified monoclonal antibody to estradiol-17 beta, with estradiol-6-carboxymethyl oxime-aminobutylethyl isoluminol as the chemiluminescent marker. The antibody is covalently coupled to polymer beads. Bound and free ligand are separated by simple centrifugation. Values so determined were compared with those determined with two different radioimmunoassay (RIA) methods, one involving the same monoclonal solid-phase antibody plus iodinated estradiol, 125I-RIA, the other a polyclonal antibody and tritiated estradiol, 3H-RIA. In the latter RIA, dextran-coated charcoal was used to separate bound and free ligand. Values determined by the three methods agreed well: for chemiluminescence vs 125I-RIA, r = 0.93; for chemiluminescence vs 3H-RIA, r = 0.94; for 125I-RIA vs 3H-RIA, r = 0.94. The three methods are similar in sensitivity, specificity, and precision. The present method is simple and reliable, taking advantage of the specificity and sensitivity intrinsic to the use of an antibody without the inconveniences associated with use of an isotopically labeled ligand.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1983 by the American Association for Clinical Chemistry.